Ribociclib is an inhibitor that targets CDK4/6 and is used for HR /HER2-positive breast cancer. It stops cells from moving forward in their growth cycle. You can get the med in 200 mg tablet form with a coating.
The recommended dose is 600 mg taken once daily, administered over a 21-day cycle within a 28-day cycle. Each blister pack has 63 tabs.
